<DOC>
	<DOCNO>NCT00216736</DOCNO>
	<brief_summary>The aim project determine single dose oral dexamethasone time discharge emergency department ( ED ) [ successful treatment ] prevents rebound headache . Hypothesis : That single dose oral dexamethasone 8mg reduces proportion patient suffer rebound headache treatment migraine ED .</brief_summary>
	<brief_title>Oral Dexamethasone Treatment Migraine</brief_title>
	<detailed_description>Migraine headache debilitate condition . A small significant proportion sufferer seek treatment emergency department [ ED ] , account 2-5 % ED visits.Available data suggest 66 % patient may experience rebound headache discharge affect ability function normally [ eg work , social , etc ] .It appear inflammation play key role recurrence . A number small study suggest single dose corticosteroid time discharge might prevent rebound headache . To date study use intravenous dexamethasone . The aim project determine single dose oral dexamethasone time discharge ED [ successful treatment ] prevents rebound headache . Hypothesis : That single dose oral dexamethasone 8mg reduces proportion patient suffer rebound headache treatment migraine ED . Aims : The primary aim compare proportion patient experience rebound headache within 48 hour ED treatment migraine group treat single dose oral dexamethasone 8mg group treat placebo . Secondary aim compare headache severity , analgesia/ health service use , adverse event return normal function group . Methods : Study design : Double blind , randomise placebo control clinical trial . Setting : Emergency Department , Western Hospital . Participants : Adult patient [ age &gt; 17 year ] physician-diagnosed migraine treat ED . Inclusion criterion : Consenting adult patient [ age &gt; 17 year ] physician-diagnosed migraine treat ED willing able contact 48-72 hour discharge follow-up . Sample size : 76 patient . Note : The study stop early operational reason . 63 patient analyse .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Consenting adult patient [ age &gt; 17 year ] physiciandiagnosed migraine treat ED willing able contacted 4872 hour discharge followup Failure consent Pregnancy Allergy study medication Findings inconsistent migraine Patients require hospital admission investigation treatment Patients active peptic ulcer disease Patients Type 1 diabetes Patients take corticosteroid another condition within 7 day Active systemic fungal infection Patients previously enrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Headache</keyword>
	<keyword>Rebound headache</keyword>
</DOC>